Boehringer Ingelheim Annual Report 2024. Chairman of the shareholders' committee: Boehringer ingelheim presents the 2021 results and an outlook for 2022 at the annual press conference on april 5, 2022 in ingelheim.
Discover in our annual report 2022 how we achieved this and on how we want to continue to transform the lives of people and animals in the future. Looking ahead, boehringer ingelheim anticipates moderate growth in 2023, on a comparable basis, with a slight increase in its operating income, creating the.
In 2022 We Were Able To Help More People Than Ever Before.
Ingelheim, germany โ 9 january 2024 โ boehringer ingelheim has kicked off 2024 on a high note by announcing that the company is entering five new r&d.
The 2022 Annual Report Consistently Continues The Development Started In.
Boehringer ingelheim presents the 2021 results and an outlook for 2022 at the annual press conference on april 5, 2022 in ingelheim.
Transforming Retinal Healthfor Individuals With Diabetes.
Images References :
Looking Ahead, Boehringer Ingelheim Anticipates Moderate Growth In 2023, On A Comparable Basis, With A Slight Increase In Its Operating Income, Creating The.
In 2022 we were able to help more people than ever before.
With This Card You Hold The.
For example, we try to avoid waste in the office and consider sustainability issues when we select suppliers.
In My Region, Boehringer Ingelheim Has Launched An Initiative Called B.